Lv1
30 积分 2026-02-03 加入
Comparison of efficacy and safety of pioglitazone and SGLT2 inhibitors in treating Asian patients in MASLD associated with type 2 diabetes: A meta-analysis
3小时前
待确认
Symptom clusters and symptom interference of HCC patients undergoing TACE: a cross-sectional study in China
5个月前
已完结
皖公网安备34019202002308
